09 Sep There is less than a 10% chance that next February there will not be at least one vaccine that is safe enough in the short term.
[caption id="attachment_16745" align="alignnone" width="400"] Miguel Ángel Temprano participate this time in the Open Market program directed by Marta Isern more in his capacity as Biochemist than as a fund manager to give his opinion on the incident caused by the interruption of the AstraZeneca clinical...